CD4+ and CD8+ skin-associated T lymphocytes in canine atopic dermatitis produce interleukin-13, interleukin-22 and interferon-γ and contain a CD25+FoxP3+ subset

Veterinary Dermatology

Volumn 25, Issue 5, 2014, Pages 456-e72

  Jassies Van Der Lee, Annette ^a   Rutten, Victor P M G ^b,c   Bruijn, Jet ^a   Willemse, Ton ^a,b   Broere, Femke ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOLOGY; DOG; DOG DISEASE; FLOW CYTOMETRY; IMMUNOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SKIN; T LYMPHOCYTE SUBPOPULATION; VETERINARY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; REAL-TIME POLYMERASE CHAIN REACTION; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 84911455668     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12140     Document Type: Article

References (42)

1. Olivry T, Naydan DK, Moore PF. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 1997; 19: 477-486.
2. Sinke JD, Thepen T, Bihari IC et al. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet Immunol Immunopathol 1997; 57: 13-23.
3. Schlotter YM, Rutten VP, Riemers FM et al. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness. Vet Immunol Immunopathol 2011; 143: 20-26.
4. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-155.
5. Howell MD, Fairchild HR, Kim BE et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128: 2248-2258.
6. Marsella R, Olivry T, Carlotti DN et al. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet Dermatol 2011; 22: 239-248.
7. Trautmann A, Akdis M, Kleemann D et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000; 106: 25-35.
8. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
9. Souwer Y, Szegedi K, Kapsenberg ML et al. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 2010; 22: 821-826.
10. Koga C, Kabashima K, Shiraishi N et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128: 2625-2630.
11. Toda M, Leung DY, Molet S et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003; 111: 875-881.
12. Duhen T, Geiger R, Jarrossay D et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10: 857-863.
13. Boniface K, Bernard FX, Garcia M et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005; 174: 3695-3702.
14. H17 T cells. J Allergy Clin Immunol 2009; 123: 1244-1252.
15. Hennino A, Vocanson M, Toussaint Y et al. Skin-infiltrating CD8 T cells initiate atopic dermatitis lesions. J Immunol 2007; 178: 5571-5577.
16. + T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 2011; 127: 1064-1067.
17. + T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. J Invest Dermatol 2013; 133: 973-979.
18. Birch KE, Vukmanovic-Stejic M, Reed JR et al. The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin. Br J Dermatol 2005; 152: 409-417.
19. Suri-Payer E, Fritzsching B. Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol 2006; 28: 3-16.
20. Dazzi F, van Laar JM, Cope A et al. Cell therapy for autoimmune diseases. Arthritis Res Ther 2007; 9: 206-215.
21. Palomares O, Yaman G, Azkur AK et al. Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010; 40: 1232-1240.
22. + regulatory T cells. Nat Immunol 2003; 4: 330-336.
23. Keppel KE, Campbell KL, Zuckermann FA et al. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Vet Immunol Immunopathol 2008; 123: 337-344.
24. high regulatory T-cell population in the dog. Immunology 2011; 132: 111-122.
25. Caproni M, Antiga E, Torchia D et al. FoxP3-expressing T regulatory cells in atopic dermatitis lesions. Allergy Asthma Proc 2007; 28: 525-528.
26. Hanafusa T, Matsui S, Murota H et al. Increased frequency of skin-infiltrating FoxP3 regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma. Clin Exp Immunol 2013; 172: 507-512.
27. Clark RA, Chong BF, Mirchandani N et al. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 2006; 126: 1059-1070.
28. Poot J, Thewissen M, Booi D et al. Characterization of skin-resident T cells using a crawl-out method and flow cytometry. Exp Dermatol 2013; 22: 554-555.
29. Willemse T. Atopic dermatitis: a review and reconsideration of diagnostic criteria. J Small Anim Pract 1986; 27: 771-778.
30. Favrot C, Steffan J, Seewald W et al. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 23-31.
31. Brinkhof B, Spee B, Rothuizen J et al. Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem 2006; 356: 36-43.
32. Spee B, Penning LC, Van Den Ingh TS et al. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol 2005; 4: 7.
33. Veenhof EZ, Rutten VP, Van Noort R et al. Evaluation of T-cell activation in the duodenum of dogs with cutaneous food hypersensitivity. Am J Vet Res 2010; 71: 441-446.
34. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
35. Fontenot JD, Rasmussen JP, Gavin MA et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142-1151.
36. Allan SE, Crome SQ, Crellin NK et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345-354.
37. + T cells. Eur J Immunol 2007; 37: 129-138.
38. high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
39. + regulatory thymocytes. Blood 2003; 102: 4107-4114.
40. + regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008; 38: 640-646.
41. Clark RA, Kupper TS. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 2007; 109: 194-202.
42. Ahmadzadeh M, Antony PA, Rosenberg SA. IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells. J Immunother 2007; 30: 294-302.